APA

Hoffman P. S., Bruce A. M., Olekhnovich I., Warren C. A., Burgess S. L., Hontecillas R., Viladomiu M., Bassaganya-Riera J., Guerrant R. L. & Macdonald T. L. (20150828). Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori. : Antimicrobial agents and chemotherapy.

Chicago

Hoffman Paul S, Bruce Alexandra M, Olekhnovich Igor, Warren Cirle A, Burgess Stacey L, Hontecillas Raquel, Viladomiu Monica, Bassaganya-Riera Josep, Guerrant Richard L and Macdonald Timothy L. 20150828. Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori. : Antimicrobial agents and chemotherapy.

Harvard

Hoffman P. S., Bruce A. M., Olekhnovich I., Warren C. A., Burgess S. L., Hontecillas R., Viladomiu M., Bassaganya-Riera J., Guerrant R. L. and Macdonald T. L. (20150828). Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori. : Antimicrobial agents and chemotherapy.

MLA

Hoffman Paul S, Bruce Alexandra M, Olekhnovich Igor, Warren Cirle A, Burgess Stacey L, Hontecillas Raquel, Viladomiu Monica, Bassaganya-Riera Josep, Guerrant Richard L and Macdonald Timothy L. Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori. : Antimicrobial agents and chemotherapy. 20150828.